{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-228351","form_type":"8-K","ticker":"ENGN","cik":"0001980845","company_name":"enGene Therapeutics Inc.","filed_at":"2025-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.207724+00:00","generated_at":"2026-05-17T04:58:17.670070+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"enGene amends CEO Ron Cooper's severance to 1.5x target bonus on change-in-control termination","bullets":["Board approved amendment to Cooper Employment Agreement, effective October 2, 2025.","CIC termination severance multiplier increased from 1.0x to 1.5x annual target bonus.","Lump sum payment payable within 45 days of CIC termination, subject to compliance.","Amendment recommended by Compensation Committee; full text to be filed in 10-K for FY ending Oct 31, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-228351","json":"https://secwatch.observer/filing/0001193125-25-228351.json","markdown":"https://secwatch.observer/filing/0001193125-25-228351.md","text":"https://secwatch.observer/filing/0001193125-25-228351.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/0001193125-25-228351-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1980845/000119312525228351/engn-20251002.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T04:58:17.670070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}